Cancer-Specific Exons as Pan-Tumor CAR-T Targets in Pediatric Solid and Brain Tumor
Abstract Chimeric antigen receptor T-cell (CAR-T) therapy has transformed the management of pediatric B-cell malignancies but has so far failed to replicate this success in solid and central nervous system tumors. The central bottleneck is not effector cell engineering but antigen identification: the spectrum of reliab...